Novartis Vaccines

Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR
Telephone: +44 (0)1276 694 490
Fax: +44 (0)1276 698 460
WWW: http://www.novartis.com
Medical Information Direct Line: +44 (0)8457 451 500
Medical Information e-mail: serviceuk@novartis.com
Medical Information Fax: +44 (0)1517 055 669
Summary of Product Characteristics last updated on the eMC: 20/08/2009
SPC IXIARO suspension for injection - Japanese encephalitis vaccine (inactivated, adsorbed)

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 20/08/2009 and displayed until Current
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 8 - MARKETING AUTHORISATION NUMBER(S)
Date of revision of text on the SPC:   01-Jul-2009
Legal Category:   POM
Black Triangle (CHM):   YES

Free-text change information supplied by the pharmaceutical company

- In section 6.5 , the availability of the suspension with AND without a needle has been clarified
- In section 8, two marketing authorisation numbers are now included which incorporate a reference to the suspension being available either with or without a needle
Updated on 08/05/2009 and displayed until 20/08/2009
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC
Date of revision of text on the SPC:  
Legal Category:   POM
Black Triangle (CHM):   YES

Free-text change information supplied by the pharmaceutical company

None provided

Active Ingredients/Generics

 
   japanese encephalitis vaccine (inactivated, adsorbed)


© 2009 Datapharm Communications Ltd

Go to www.medicines.org.uk